Chronic Lymphocytic Leukemia | Recent Advances in Hematologic Oncology: A 4-Part Live Webinar Series Reviewing Key Data and Presentations from the 62nd ASH Annual Meeting — Chronic Lymphocytic Leukemia (Part 4)
Proceedings from part 4 of a 4-part webinar series. Featuring
perspectives from Drs Paul M Barr, Matthew S Davids and Kerry
Rogers, including the following topics:
Introduction (0:00)
Available and emerging data with Bruton tyrosine kinase
inhibitors for chronic lymphocytic leukemia (CLL) (0:53)
Role of Bcl-2 inhibitors for CLL (26:46)
Novel strategies under investigation for CLL — U2 regimen
(umbralisib/ublituximab) and CAR (chimeric antigen receptor) T-cell
therapy (50:17)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.